GlassScriptPhysician profile
Mary A Alt
NPI 1326076498
$932.89
in general payments reported to CMS, 2019-2025
18 companies · $60.60 in 2025
The $60.60 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $132 · 2023: $288 · 2024: $73.09 · 2025: $60.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $284.26 | 2021-2025 | Lifevest |
| Pfizer INC. | $107.70 | 2021-2024 | |
| Abbott Laboratories | $92.14 | 2021-2023 | Amplatzer Amulet, Cardiomems |
| Novartis Pharmaceuticals Corporation | $84.99 | 2021-2023 | |
| Chiesi USA, INC. | $50.88 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $49.37 | 2021 | |
| Amarin Pharma, INC. | $42.95 | 2021 | |
| Impulse Dynamics (USA) INC. | $37.88 | 2023 | Optimizer |
| Lantheus Medical Imaging, INC. | $29.63 | 2023 | Definity |
| Amgen INC. | $27.16 | 2023 | Repatha |
| Lexicon Pharmaceuticals, INC. | $22.30 | 2023 | Inpefa |
| Teleflex LLC | $18.62 | 2024 | Guideliner |
| Arbor Pharmaceuticals, INC. | $15.75 | 2021 | |
| Silk Road Medical, INC. | $15.75 | 2022 | |
| Amryt Pharma Holdings LTD | $15.24 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.33 | 2021 | |
| Medtronic, INC. | $12.05 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Alt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.